Your browser doesn't support javascript.
loading
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021
Phillip P. Salvatore; Christine C. Lee; Sadia Sleweon; David W. McCormick; Lavinia Nicolae; Kristen Knipe; Thomas Dixon; Robert Banta; Isaac Ogle; Cristen Young; Charles Dusseau; Shawn Salmonson; Charles Ogden; Eric Godwin; TeCora Ballom; Tara Ross; Nhien Tran Wynn; Ebenezer David; Theresa K. Bessey; Gimin Kim; Suganthi Suppiah; Azaibi Tamin; Jennifer L. Harcourt; Mili Sheth; Luis Lowe; Hannah Browne; Jacqueline E. Tate; Hannah L. Kirking; Liesl M. Hagan.
Affiliation
  • Phillip P. Salvatore; U.S. Centers for Disease Control & Prevention
  • Christine C. Lee; U.S. Centers for Disease Control & Prevention
  • Sadia Sleweon; U.S. Centers for Disease Control & Prevention
  • David W. McCormick; U.S. Centers for Disease Control & Prevention
  • Lavinia Nicolae; U.S. Centers for Disease Control & Prevention
  • Kristen Knipe; U.S. Centers for Disease Control & Prevention
  • Thomas Dixon; Bureau of Prisons, U.S. Department of Justice
  • Robert Banta; Bureau of Prisons, U.S. Department of Justice
  • Isaac Ogle; Bureau of Prisons, U.S. Department of Justice
  • Cristen Young; Bureau of Prisons, U.S. Department of Justice
  • Charles Dusseau; Bureau of Prisons, U.S. Department of Justice
  • Shawn Salmonson; Bureau of Prisons, U.S. Department of Justice
  • Charles Ogden; Bureau of Prisons, U.S. Department of Justice
  • Eric Godwin; Bureau of Prisons, U.S. Department of Justice
  • TeCora Ballom; Bureau of Prisons, U.S. Department of Justice
  • Tara Ross; Bureau of Prisons, U.S. Department of Justice
  • Nhien Tran Wynn; U.S. Centers for Disease Control & Prevention
  • Ebenezer David; U.S. Centers for Disease Control & Prevention
  • Theresa K. Bessey; U.S. Centers for Disease Control & Prevention
  • Gimin Kim; U.S. Centers for Disease Control & Prevention
  • Suganthi Suppiah; U.S. Centers for Disease Control & Prevention
  • Azaibi Tamin; U.S. Centers for Disease Control & Prevention
  • Jennifer L. Harcourt; U.S. Centers for Disease Control & Prevention
  • Mili Sheth; U.S. Centers for Disease Control & Prevention
  • Luis Lowe; U.S. Centers for Disease Control & Prevention
  • Hannah Browne; U.S. Centers for Disease Control & Prevention
  • Jacqueline E. Tate; U.S. Centers for Disease Control & Prevention
  • Hannah L. Kirking; U.S. Centers for Disease Control & Prevention
  • Liesl M. Hagan; U.S. Centers for Disease Control & Prevention
Preprint in English | medRxiv | ID: ppmedrxiv-21265796
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
BackgroundThe extent to which vaccinated persons who become infected with SARS-CoV-2 contribute to transmission is unclear. During a SARS-CoV-2 Delta variant outbreak among incarcerated persons with high vaccination rates in a federal prison, we assessed markers of viral shedding in vaccinated and unvaccinated persons. MethodsConsenting incarcerated persons with confirmed SARS-CoV-2 infection provided mid-turbinate nasal specimens daily for 10 consecutive days and reported symptom data via questionnaire. Real-time reverse transcription-polymerase chain reaction (RT-PCR), viral whole genome sequencing, and viral culture was performed on these nasal specimens. Duration of RT-PCR positivity and viral culture positivity was assessed using survival analysis. ResultsA total of 978 specimens were provided by 95 participants, of whom 78 (82%) were fully vaccinated and 17 (18%) were not fully vaccinated. No significant differences were detected in duration of RT-PCR positivity among fully vaccinated participants (median 13 days) versus those not fully vaccinated (median 13 days; p=0.50), or in duration of culture positivity (medians 5 days and 5 days; p=0.29). Among fully vaccinated participants, overall duration of culture positivity was shorter among Moderna vaccine recipients versus Pfizer (p=0.048) or Janssen (p=0.003) vaccine recipients. ConclusionsAs this field continues to develop, clinicians and public health practitioners should consider vaccinated persons who become infected with SARS-CoV-2 to be no less infectious than unvaccinated persons. These findings are critically important, especially in congregate settings where viral transmission can lead to large outbreaks.
License
cc0
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
...